Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease

Title
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume 12, Issue 9, Pages 1389-1395
Publisher
American Chemical Society (ACS)
Online
2021-08-10
DOI
10.1021/acsmedchemlett.1c00048

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More